Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 170
Selected: 0
NCT IDTitle
NCT01407562Study of Pazopanib, Paclitaxel, and Carboplatin in Patients With Advanced Solid Tumors
NCT01617161Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
NCT02621398Pembrolizumab, Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients With Stage II-IIIB Non-Small Cell Lung Cancer
NCT00770419Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers
NCT02117817Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer
NCT00726596Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer
NCT00176644Phase II Trial of Transdermal Estradiol for Hormone Refractory Prostate Cancer
NCT00176501Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer
NCT03061175Web-Based Decision Aid in Improving Informed Decisions in Patients With Stage 0-IIIA Breast Cancer Considering Contralateral Prophylactic Mastectomy
NCT02202044Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection
NCT00176475Irradiated Donor Lymphocytes and Rituximab in Treating Patients With Relapsed or Refractory Lymphoproliferative Disease
NCT00118066Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia
NCT01220973Atorvastatin Calcium and Celecoxib in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer
NCT02458716Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer
NCT00996359Partially HLA-Matched Irradiated Allogeneic Cellular Therapy After Reduced Intensity Total Body Irradiation
NCT04829383A Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
NCT0000405812-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder
NCT02324621Continuation of Oral ONC201 in Treating Patients With Advanced Solid Tumors
NCT04445844INCMGA00012 and Pelareorep for the Treatment of Metastatic Triple Negative Breast Cancer, IRENE Study
NCT02885649Enzalutamide Before Surgery in Treating Patients With Kidney Cancer
NCT06518837Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer
NCT04285268Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
NCT06002282HPV Vaccine Confident Families
NCT01006369Hydroxychloroquine, Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
NCT00578240Molecular Studies and Clinical Correlations in Human Prostatic Disease
NCT04751747Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer
NCT06704295High Impact E-cigarette Advertisement Features
NCT00323063Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer
NCT01417286Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer
NCT03272633Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
NCT02324608Cetuximab Before Surgery in Treating Patients With Aggressive Locally Advanced Skin Cancer
NCT01711944Online Problem Solving Skills Training
NCT00156299Gene Expression During Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Choline Magnesium Trisalicylate
NCT01018836Riluzole and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
NCT00295932Bortezomib, Rituximab, Cyclophosphamide, and Prednisone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma
NCT07210567Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors
NCT03229278Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma
NCT03382158International PPB/DICER1 Registry
NCT00138151Isotretinoin, Interferon Alpha-2b, and Paclitaxel in Stage IV, Recurrent, or Persistent Cervical Cancer
NCT03102060Gluten Free Diet in Preventing Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplant
NCT01982058Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer
NCT01032590Internet-Based Weight-Loss Program for Colorectal Cancer Survivors
NCT00853125Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer
NCT04146038Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease
NCT04211259Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization
NCT00608972Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
NCT01510119Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma
NCT00176527Isotretinoin, Interferon Alfa-2b, Docetaxel, and Estramustine in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy
NCT00891969Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions
NCT00728845Hydroxychloroquine, Carboplatin, Paclitaxel, and Bevacizumab in Recurrent Advanced Non-Small Cell Lung Cancer